Fatty acid binding protein 6 is overexpressed in colorectal cancer

Clinical Cancer Research

Volumn 12, Issue 17, 2006, Pages 5090-5095

  Ohmachi, Takahiro ^a,b,c   Inoue, Hiroshi ^a,b   Mimori, Koshi ^a,b   Tanaka, Fumiaki ^a,b   Sasaki, Atsushi ^a,b   Kanda, Tatsuo ^d   Fujii, Hiroshi ^d   Yanaga, Katsuhiko ^c   Mori, Masaki ^a,b  

^a KYUSHU UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NIIGATA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID BINDING PROTEIN; FATTY ACID BINDING PROTEIN 6; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

ADENOMA; AGED; COLORECTAL NEOPLASMS; FATTY ACID-BINDING PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33749039497     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-05-2045     Document Type: Article

References (25)

1. Galloway DJ, Owen RW, Jarrett F, Boyle P, Hill MJ, George WD. Experimental colorectal cancer: the relationship of diet and faecal bile acid concentration to tumour induction. Br J Surg 1986;73:233-7.
2. Narisawa T, Reddy BS, Weisburger JH. Effect of bile acids and dietary fat on large bowel carcinogenesis in animal models. Gastroenterol Jpn 1978;13:206-12.
3. Rainey JB, Davies PW, Bristol JB, Williamson RC. Adaptation and carcinogenesis in defunctioned rat colon: divergent effects of faeces and bile acids. Br J Cancer 1983;48:477-84.
4. Bernstein C, Bernstein H, Garewal H, et al. A bile acid-induced apoptosis assay for colon cancer risk and associated quality control studies. Cancer Res 1999;59:2353-7.
5. Venturi M, Hambly RJ, Glinghammar B, Rafter JJ, Rowland IR. Genotoxic activity in human faecal water and the role of bile acids: a study using the alkaline comet assay. Carcinogenesis 1997;18:2353-9.
6. Mori M, Mimori K, Yoshikawa Y, et al. Analysis of the gene-expression profile regarding the progression of human gastric carcinoma. Surgery 2002;131:S39-47.
7. Ogawa K, Utsunomiya T, Mimori K, et al. Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer. Clin Cancer Res 2005;11:2889-93.
8. Fujii H, Nomura M, Kanda T, et al. Cloning of a cDNA encoding rat intestinal 15 kDa protein and its tissue distribution. Biochem Biophys Res Commun 1993;190:175-80.
9. Adrain C, Slee EA, Harte MT, Martin SJ. Regulation of apoptotic protease activating factor-1 oligomerization and apoptosis by the WD-40 repeat region. J Biol Chem 1999;274:20855-60.
10. Albini A, Iwamoto Y, Kleinman HK, et al. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 1987;47:3239-45.
11. Patel T, Gores GJ, Kaufmann SH. The role of proteases during apoptosis. FASEB J 1996;10:587-97.
12. Keler T, Sorof S. Growth promotion of transfected hepatoma cells by liver fatty acid binding protein. J Cell Physiol 1993;157:33-40.
13. Hashimoto T, Kusakabe T, Watanabe K, et al. Liver-type fatty acid-binding protein is highly expressed in intestinal metaplasia and in a subset of carcinomas of the stomach without association with the fatty acid synthase status in the carcinoma. Pathobiology 2004;71:115-22.
14. Jing C, Beesley C, Foster CS, et al. Identification of the messenger RNA for human cutaneous fatty acid-binding protein as a metastasis inducer. Cancer Res 2000;60:2390-8.
15. Adamson J, Morgan EA, Beesley C, et al. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene 2003;22:2739-49.
16. Godbout R, Bisgrove DA, Shkolny D, Day RS 3rd, Correlation of B-FABP and GFAP expression in malignant glioma. Oncogene 1998;16:1955-62.
17. Sinha P, Hutter G, Kottgen E, Dietel M, Schadendorf D, Lage H. Increased expression of epidermal fatty acid binding protein, cofilin, and 14-3-3-sigma (stratifin) detected by two-dimensional gel electrophoresis, mass spectrometry and microsequencing of drug-resistant human adenocarcinoma of the pancreas. Electrophoresis 1999;20:2952-60.
18. Hashimoto T, Kusakabe T, Sugino T, et al. Expression of heart-type fatty acid-binding protein in human gastric carcinoma and its association with tumor aggressiveness, metastasis and poor prognosis. Pathobiology 2004;71:267-73.
19. Watanabe R, Fujii H, Yamamoto A, et al. Immunohistochemical distribution of cutaneous fatty acid-binding protein in human skin. J Dermatol Sci 1997;16:17-22.
20. Imray CH, Radley S, Davis A, et al. P. Faecal unconjugated bile acids in patients with colorectal cancer or polyps. Gut 1992;33:1239-45.
21. Korpela JT, Adlercreutz H, Turunen MJ. Fecal free and conjugated bile acids and neutral sterols in vegetarians, omnivores, and patients with colorectal cancer. Scand J Gastroenterol 1988;23:277-83.
22. Hill MJ, Melville DM, Lennard-Jones JE, Neale K, Ritchie JK. Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet 1987;2:185-6.
23. Kurtz WJ, Leuschner U. Bile acids in patients suffering from colorectal carcinoma - a pilot study. Tokai J Exp Clin Med 1983;8:59-69.
24. Kleine AH, Glatz JF, Van Nieuwenhoven FA, Van der Vusse GJ. Release of heart fatty acid-binding protein into plasma after acute myocardial infarction in man. Mol Cell Biochem 1992;116:155-62.
25. Rauch J, Ahlemann M, Schaffrik M, et al. Allogenic antibody-mediated identification of head and neck cancer antigens. Biochem Biophys Res Commun 2004;323:156-62.